Recherche avancée
Affichage des résultats 6181 à 6200 sur 8264 au total
-
Causality and statistical association (2) Mechanical determinism and stochastic model
François Gueyffier, Michel Cucherat
-
La modélisation des interactions en pharmacologie : un outil d'intégration des connaissances complexes
Samira Bakiri, Marie-Aimée Dronne, S. Randall Thomas, François Gueyffier
-
[Readability of informed consent forms for subjects participating in biomedical research: updating is required]
Adeline Paris, Jean-Luc Cracowski, Nadia Ravanel, Catherine Cornu, François Gueyffier, Béatrice Deygas, Karine Guillot, Jean-Luc Bosson, Marc Hommel
-
Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock
G. Monneret, A. Lepape, N. Voirin, J. Bohé, F. Venet, A.-L. Debard, H. Thizy, J. Bienvenu, François Gueyffier, Philippe Vanhems
-
Critères intermédiaires et critères de substitution
Behrouz Kassai, François Gueyffier, J-P. Boissel
-
Do We Need to Assess the Effect of Treatment Withdrawal? The Paradigm of Life-Long Prevention
François Gueyffier, T. Bejan-Angoulvant
-
Some reflexions about double blind
R. Boussageon, François Gueyffier, A. Moreau, Y. Gansel, V. Boussageon
-
Cognitive Therapy versus Rogerian Supportive Therapy in Borderline Personality Disorder
J. Cottraux, I. Druon Note, F. Boutitie, M. Milliery, V. Genouihlac, S.N. Yao, B. Note, E. Mollard, F. Bonasse, Sophie Gaillard, D. Djamoussian, Mey C. De, A. Culem, François Gueyffier
-
The Global Risk Approach Should Be Better Applied in French Hypertensive Patients: A Comparison between Simulation and Observation Studies
I. Marchant, Patrice Nony, Michel Cucherat, J-P. Boissel, S.R. Thomas, T. Bejan-Angoulvant, A. Laugerotte, R. Kahoul, François Gueyffier
-
Programmed death-1 levels correlate with increased mortality, nosocomial infection and immune dysfunctions in septic shock patients.
Caroline Guignant, Alain Lepape, Xin Huang, Hakim Kherouf, Laure Denis, Françoise Poitevin, Christophe Malcus, Aurélie Chéron, Bernard Allaouchiche, François Gueyffier, Alfred Ayala, Guillaume Monneret, Fabienne Venet
-
Effect of intensive glucose lowering treatment on all cause mortality cardiovascular death and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials
R. Boussageon, T. Bejan-Angoulvant, M. Saadatian-Elahi, S. Lafont, C. Bergeonneau, Behrouz Kassai, S. Erpeldinger, Jm. Wright, François Gueyffier, Catherine Cornu
-
Programmed death-1 levels correlate with increased mortality nosocomial infection and immune dysfunctions in septic shock patients
C. Guignant, C. Lepage, X. Huang, H. Kherouf, L. Denis, F. Poitevin, C. Malcus, A. Chéron, B. Allaouchiche, François Gueyffier, A. Ayala, G. Monneret, F. Venet
-
Individual patient data meta-analysis of survival data using Poisson regression models.
Michael Crowther, Richard Riley, Jan Staessen, Jiguang Wang, Francois Gueyffier, Paul Lambert
-
Pharmacotherapy for mild hypertension (Review)
D. Diao, Jm. Wright, Dk. Cundiff, François Gueyffier
-
Modeling the impact of cardiovascular prevention strategies: toward better information for public health decisions
François Gueyffier, I. Marchant, B. Carlberg
-
Oseltamivir-zanamivir bitherapy compared to oseltamivir monotherapy in the treatment of pandemic 2009 influenza A(H1N1) influenza virus infections
V. Escuret, C. Cornu, F. Boutitie, V. Ernouf, A. Mosnier, M. Bouscambert-Duchamp, S. Gaillard, X. Duval, T. Blanchon, C. Leport, François Gueyffier, S. van Der Werf, B. Lina
-
Farnesoid X Receptor Targeting for Hepatitis C: Study Protocol for a Proof-of-concept Trial
C. Scholtes, P. Andre, C. Trepo, C. Cornu, Laurent Remontet, René Ecochard, Théodora Bejan-Angoulvant, François Gueyffier
-
The IDEAL Study : Towards Personalized Drug Treatment of Hypertension
T. Bejan-Angoulvant, J-P. Baguet, S. Erpeldinger, J-M. Boivin, A. Mercier, G. Leftheriotis, J-P. Gagnol, J-P. Fauvel, C. Giraud, G. Bricca, François Gueyffier
-
Traitement anti-hypertenseur et tabac
R. Boussageon, G. Grand, François Gueyffier
-
Pharmacoepidemiology studies: what levels of evidence and how can they be reached?
Maryse Lapeyre-Mestre, Claudine Sapède, Nicholas Moore, Pascal Bilbault, Patrick Blin, Damien Chopy, David Evans, François Gueyffier, Laure Lacoin, Muriel Malbezin, Joëlle Micallef, Dana Morlet-Vigier, Sophie Muller, Emmanuel Oger, Yannick Plétan, Gérard Pons, Patrice Verpillat, Caroline Vigneau